Page 48 - 74_01
P. 48

MIGUEL F. BRAÑA Y COLS.  AN. R. ACAD. NAC. FARM.

(27)  WALLING, J. M.; DEACON, J.; HOLLIDAY, S. y STRATFORD, I. J. (1989): High Uptake
(28)  of RSU 1069 and its Analogues into Melanotic Melanomas. Cancer Chemo-
(29)  ther. Pharmacol. 24: 28-32.
(30)  OLIVEIRA, R. B. y ALVES, R. J. (2002): Agentes Antineoplásicos Biorredutíveis:
(31)  Uma Nova Alternativa para o Tratamento de Tumores Sólidos. Quim. Nova.
      25: 976-984.
(32)  MARETIC, Z. (1959): Treatment of Amebiasis and Other Intestinal Affection
      with Entobex. Ann. Soc. Belg. Med. Trop. 39: 653-662.
(33)  BROWN, J. M. (1993): SR 4233 (Tirapazamine): a New Anticancer Drug Explit-
(34)  ing Hyposia in Solid Tumors. Br. J. Cancer. 67: 1163-1170.
(35)  CERECETTO, H.; DI MAIO, R.; GONZÁLEZ, M.; RISSO, M.; SÁENZ, P.; SEOANE, G.;
(36)  DENICOLA, A.; PELUFFO, G.; QUIJANO, C. y OLEA-AZAR, C. (1999): 1,2,5,-Oxadiazo-
(37)  le N-Oxide Derivatives and Realted Compounds as Potential Antitrypanoso-
(38)  mal Drugs: Structure-Activity Relationships. J. Med. Chem. 42: 1941-1950.
      ARCAMONE, F. M.; ANIMATI, F; BARBIERI, B.; CONFIGLIACHI, E.; D’ALESSIO, R.; GE-
(39)  RONI, C.; GIULIANI, F. C.; LAZZARI, E.; MENOZZI, M. y MONGELLI (1989): Synthesis,
(40)  DNA-Binding Properties, and Antitumor Activity of Novel Distamycin Deri-
      vatives. J. Med. Chem. 32: 774-778.
      MUTALIK, G. S.; GULATI, R. B. e IQBAL, A. K. (1975): A field Trial with Bitosca-
      nate in India. Prog. Drug. Res. 19: 81-85.
      BRAÑA, M. F.; AÑORBE, L. y DOMÍNGUEZ, G. (1999): Angiogenesis and Cancer:
      the Contribution of Organic Chemistry. Rev. Oncol. 1: 122-132.
      FEIGON, J.; DENNY, W. A.; LEUPIN, W. y KEARNS, D. R. (1984): Interactions of
      Antitumor Drugs with DNA: 1H-NMR Study of Binding Mode and Kinetics.
      J. Med. Chem. 27: 450-465.
      BRAÑA, M. F.; CACHO, M.; GRADILLAS, A.; PASCUAL-TERESA, B. y RAMOS, A. (2001):
      Intercalators as Anticancer Drugs. Curr. Pharm. Design. 7: 1745-1780.
      CASTEEL, D. A. (1997): Antimalarial Agents en Burrger’s Medicinal Chemistry
      and Drug Discovery. Vol. 5. Ed. WOLFF, M.E. J. Wiley. Nueva York. 3-91.
      CASTANYS, S.; OSUNA, A.; GAMARRO, F.; RUIZ, L. M.; JERÓNIMO, N.; JERÓNIMO, M.
      C.; ROLDÁN, C. M. y BRAÑA, M. F. (1984): Acción in vivo de tres derivados de
      benzo[de]isoquinolein-1,3-diona sobre tripanosoma cruzi. Laboratorio (Gra-
      nada) 77: 459-487.
      BRAÑA, M. F. y RAMOS, A. (2001): Naphthalimides as Anticancer Agents:
      Synthesis and Biological Activity. Curr. Med. Chem. - Anti-Cancer Agents. I:
      237-255.
      ZINSSTAG, J.; BRUN, R. y GESSLER, M. (1991): A New Photometric Assay for
      Testing Trypanocidal Activity in vitro. Parasitol. Res. 77: 33-38.

50
   43   44   45   46   47   48   49   50   51   52   53